MedTrace Logo

MR-guided Focal Laser Ablation of the Prostate

NCT02200809 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-04-24

No results posted yet for this study

Summary

Purpose of the investigators study is to determine the short and medium term histological cancer control of focal therapy using MR-guided focal laser ablation therapy in the treatment of localised prostate cancer.

Conditions

Interventions

DEVICE

MR-guided focal laser ablation

Sponsors & Collaborators

  • Canisius-Wilhelmina Hospital

    collaborator OTHER

  • Ziekenhuisgroep Twente

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Jurgen Futterer, MD, PhD · Radboud University Nijmegen Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02200809 on ClinicalTrials.gov